Article info
PDFOriginal research
Ethics and ego dissolution: the case of psilocybin
- Correspondence to Dr William R Smith, Psychiatry, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA 19083, USA; William.Smith{at}pennmedicine.upenn.edu
Citation
Ethics and ego dissolution: the case of psilocybin
Publication history
- Received January 14, 2020
- Revised March 12, 2020
- Accepted April 6, 2020
- First published May 27, 2020.
Online issue publication
January 07, 2022
Article Versions
- Previous version (7 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis
- Psychedelic crossings: American mental health and LSD in the 1970s
- Research abuses against people of colour and other vulnerable groups in early psychedelic research
- Psilocybin-assisted therapy for reducing alcohol intake in patients with alcohol use disorder: protocol for a randomised, double-blinded, placebo-controlled 12-week clinical trial (The QUANTUM Trip Trial)
- Prescribing meaning: hedonistic perspectives on the therapeutic use of psychedelic-assisted meaning enhancement
- UK medical students’ self-reported knowledge and harm assessment of psychedelics and their application in clinical research: a cross-sectional study
- Chronic pain and psychedelics: a review and proposed mechanism of action
- PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS
- Perioperative considerations for patients exposed to hallucinogens
- Pharmacotherapy of anxiety disorders in the 21st century: A call for novel approaches